News

The agreement includes joint work in support of potential remedies and to identify effective ways to provide information and education to medical professionals and patients globally. The University

The Altropane Phase III program, called Poet-2, is designed to confirm the diagnostic utility of Altropane in anticipation of drug registration, and includes two, parallel clinical studies enrolling

Impax has filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic version of Renvela with the FDA. Following receipt of the notice

With this move, Covance will build strategic relationships with investigators, sites, and regulatory authorities in a region known for its potential to contribute to high-quality global clinical trial

Ms Hagerty succeeds Lawrence Dolin, co-founder of Noteworthy. Mr Dolin will continue to serve on the board of directors and work with the company as a consultant. Ms

Mr Broek is founder and managing partner of HSMR Advisors, a US-based fund manager with an investment emphasis on small and mid-cap biotech public companies. During his career

Before Humana, Lord was president of Health Dialog in Boston, where he helped pioneer e-enabled health care. He has also served as chief operating officer of the American

SARcode, a biopharmaceutical company, has announced the results of its Phase I randomized, double-masked, placebo-controlled trial of the safety, tolerability, and pharmacokinetics of single- and multiple-escalating doses of

Halozyme Therapeutics, a biopharmaceutical company, has commenced patient dosing in a Phase I clinical trial with PEGPH20 in cancer patients with refractory solid tumors. This multi-center, open-label, dose-escalation